THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 06:58 am
THELMA Therapeutics Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 3,215.65 million compared to KRW 2,017.5 million a year ago. Net loss was KRW 1,369.77 million compared to KRW 4,295.7 million a year ago.
For the nine months, sales was KRW 7,525.3 million compared to KRW 5,247.52 million a year ago. Net loss was KRW 8,317.39 million compared to KRW 11,991.96 million a year ago.